Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022
Wed, August 10, 2022

Mayank Mamtani Maintained (ALT) at Strong Buy with Increased Target to $26 on, Aug 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-26-on-aug-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mayank Mamtani of B. Riley Securities, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Increased Target from $21 to $26 on, Aug 12th, 2022.

Mayank has made no other calls on ALT in the last 4 months.



There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Mayank's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mayank


  • Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, May 18th, 2022

Publication Contributing Sources